Found 7 matching trials
Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BEA 2180 BR in Healthy Male Subjects PHASE1 Main study: To investigate safety, tolerability, pharmacodynamics (PD) and ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male Volunteers PHASE1 Study to investigate safety and tolerability of single, inhaled doses (2.5 ...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD) PHASE3 Comparison of lung function response between tiotropium inhalation solution...
Show More Location
Boehringer Ingelheim Investigational Site
Learn More & Join Trial
12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD PHASE3 The primary objective was to compare the bronchodilator efficacy of two dos...
Show More Location
Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPD NA This study is designed to directly compare the effects of widely available ...
Show More Location
II Department of Lung Diseases, Lung Cancer and Internal Diseases
Learn More & Join Trial
Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma PHASE2 Study Comparing the Efficacy and Safety of PT001 to Placebo and Open-label ...
Show More Learn More & Join Trial
Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD PHASE3 Non-inferiority of lung function response to Tiotropium inhalation solution...
Show More Location
Division of Pulmonary and Critical Care Medicine
Learn More & Join Trial